Kempen Capital Management N.V. Gilead Sciences, Inc. Transaction History

Kempen Capital Management N.V.

$9.59 Billion
Q3 2024

A detailed history of Kempen Capital Management N.V. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kempen Capital Management N.V. holds 502,814 shares of GILD stock, worth $47.2 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

502,814

Previous 548,988 8.41%

Holding current value

$47.2 Million

Previous $37.7 Million 11.89%

% of portfolio

0.44%

Previous 0.43%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $3.07 Million - $3.88 Million	-46,174 Reduced 8.41%	502,814 $42.1 Million
Q2 2024 Jul 24, 2024	BUY	$63.15 - $72.88 $1.98 Million - $2.28 Million	31,332 Added 6.05%	548,988 $37.7 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $1.61 Million - $1.97 Million	22,526 Added 4.55%	517,656 $37.9 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $1.21 Million - $1.37 Million	16,505 Added 3.45%	495,130 $40.1 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $15.5 Million - $16.9 Million	209,731 Added 78.0%	478,625 $35.9 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $4.8 Million - $5.48 Million	63,149 Added 30.69%	268,894 $20.7 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $4.24 Million - $6.09 Million	-68,103 Reduced 24.87%	205,745 $17.7 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $3.14 Million - $3.59 Million	-52,793 Reduced 16.16%	273,848 $16.9 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $4.09 Million - $4.61 Million	-70,901 Reduced 17.83%	326,641 $20.2 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $3.18 Million - $3.99 Million	54,939 Added 16.04%	397,542 $23.6 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $33,867 - $38,440	-522 Reduced 0.15%	342,603 $24.9 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $1.34 Million - $1.45 Million	-19,856 Reduced 5.47%	343,125 $24 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $152,137 - $166,231	2,397 Added 0.66%	362,981 $25 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $888,840 - $1.01 Million	14,814 Added 4.28%	360,584 $23.3 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $3.53 Million - $4.03 Million	62,378 Added 22.01%	345,770 $20.1 Million
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $3.87 Million - $4.87 Million	62,340 Added 28.2%	283,392 $17.9 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $1.18 Million - $1.36 Million	-16,245 Reduced 6.85%	221,052 $17 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $12.4 Million - $15.9 Million	-197,621 Reduced 45.44%	237,297 $17.7 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $72,958 - $80,251	-1,184 Reduced 0.27%	434,918 $28.3 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $3.47 Million - $3.84 Million	55,590 Added 14.61%	436,102 $27.6 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $1.29 Million - $1.45 Million	-20,923 Reduced 5.21%	380,512 $25.7 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.72 Million - $1.93 Million	27,555 Added 7.37%	401,435 $26.1 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $235,500 - $307,310	3,890 Added 1.05%	373,880 $23.4 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $3.33 Million - $3.68 Million	46,690 Added 14.44%	369,990 $28.6 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $21 Million - $24.5 Million	323,300 New	323,300 $22.9 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kempen Capital Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Kempen Capital Management N.V. with notifications on news.

Account

Kempen Capital Management N.V. Gilead Sciences, Inc. Transaction History